Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical jargon and the complexity of medical information may cause misunderstandings and patient discomfort when bedside case presentations are taking place. To see if outside-the-room case presentations were more effective, the researchers examined the patients’ average knowledge of three dimensions of their medical care in both settings — understanding their disease, the therapeutic approach being used, and further plans for care.
Allergy & Immunology July 6th 2021
Healthgrades for Professionals
There are several reasons why the COVID-19 Delta variant – responsible for the COVID crisis in India – has public health experts and doctors concerned, including its transmissibility and disease severity. You likely already know the Delta “variant of concern” is more contagious than previous variants (denoted by the Greek alphabet), but here are five other important details you should be aware of.
KevinMD.com
In this article/podcast from KevinMD.com, the author encourages readers to make some adjustments in their life to reduce the professional and personal risks associated with the stakeholders who target physicians, including corporate America, the government, patients, and the financial industry. The commentary is a response to President Biden’s multi-trillion spending plan, which targets rich corporations and wealthy individual Americans making more than $400,000.
Allergy & Immunology June 28th 2021
Pediatrics (AAP)
The recommendations from the American Academy of Pediatrics (AAP) are an update to the group’s 2012 policy statement in an effort to better equip physicians with the necessary knowledge to accurately screen, evaluate, and manage the risk of both sudden cardiac arrest (SCA) and sudden cardiac death (SCD) in youth. Screening for all children, regardless of athletic status, should be completed at least every three years.
Cardiology June 28th 2021
JAMA Network
In this JAMA Oncology Narrative Review, the authors attempt to discover whether cardiovascular risks may be associated with the multimodal approach, including systemic therapies and breast radiotherapy (RT), in treating breast cancer patients. Although recent advancements in breast cancer treatment have led to a decrease in mortality rates, the prevalence of survivors with a potentially high CV disease risk has increased.
Cardiology June 21st 2021
The data was presented to the FDA, which reported 789 cases of myocarditis/pericarditis – predominantly in males – after receiving the Pfizer/BioNTech and Moderna vaccines, most commonly after the second dose. Symptoms included chest pain, elevated cardiac enzymes, ST or T wave changes, dyspnea, and abnormal echocardiography/imaging for those ages 30 years and younger.
Cardiology June 15th 2021